Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Baseline staging tests for breast cancer

Andrew L. Cooke
CMAJ February 19, 2002 166 (4) 419;
Andrew L. Cooke
CancerCare Manitoba Winnipeg, Man.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Metrics
  • Responses
  • PDF
Loading

The Breast Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative has published their recommendations for baseline staging tests in breast cancer.1 I wish to take issue with the recommendation that ultrasonography of the liver be done routinely in patients with stage III breast cancer. The authors suggest that a test that detects metastases in more than 1% of patients is clinically useful and therefore that ultrasonography should be used in this group of patients; however, in their Table 3 the 95% confidence interval for the percentage of patients with stage III cancer who had a positive result with liver ultrasonography ranges from 0.4% to 3.6%.

The papers that they quote do not support the routine use of liver ultrasonography. In the largest study, which is twice as large as all other studies combined, only 28% of patients with stage III cancer were sent for liver ultrasonography.2 This low compliance rate suggests that there may well have been selection biases. The detection rate was 0% in patients with stage IIIA cancer and 0.85% in those with stage IIIB cancer. Furthermore, ultrasonography had a positive predictive value of only 33%, indicating that it represents an expensive wild goose chase 2 out of 3 times.

In another paper referenced by the authors there was only 1 positive liver ultrasound in 24 patients with stage III cancer.3 The authors of this paper suggested that ultrasound should be abandoned in this group of patients.

If the incidence of asymptomatic liver metastases in patients with stage III breast cancer is 1–2%, then approximately $30 000 will be spent in ultrasonography to find 1 case of liver metastasis. Because the patient would probably receive some form of chemotherapy anyway and there would be little if any effect on the patient's life expectancy, there would be no cost saving to the system of any substance and no effect on mortality. Surely, then, routine staging ultrasonography cannot be justified in this group of patients.

References

  1. 1.↵
    Myers RE, Johnston M, Pritchard K, Levine M, Oliver T, and the Breast Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative. CMAJ 2001;164(10):1439-44.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Ciatto S, Pacini P, Azzini V, Neri A, Jannini A, Gosso P, et al. Preoperative staging of breast cancer. A multicentric study. Cancer 1988;61: 1038-40.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Clark CP, Foreman ML, Peters GN, Cheek JH, Sparkman RS. Efficacy of preoperative liver function tests and ultrasound in detecting hepatic metastasis in carcinoma of the breast. Surg Gynecol Obstet 1988;167:510-4.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

CMAJ
Vol. 166, Issue 4
19 Feb 2002
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Baseline staging tests for breast cancer
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Baseline staging tests for breast cancer
Andrew L. Cooke
CMAJ Feb 2002, 166 (4) 419;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Baseline staging tests for breast cancer
Andrew L. Cooke
CMAJ Feb 2002, 166 (4) 419;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Respiratory syncytial virus and palivizumab prophylaxis in the COVID-19 era
  • Eliminating racism in research
  • Transitioning to outpatient arthroplasty during COVID-19: time to pivot
Show more Letters

Similar Articles

Collections

  • Sections
    • Guidelines
  • Topics
    • Cancer: breast

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, CMA Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of the resources on this site in an accessible format, please contact us at cmajgroup@cmaj.ca.

Powered by HighWire